Search

Iris Lee

from Buena Park, CA
Get Report
Related to:
Bong H Lee, 68Tae H KimSook J Lee, 75Jun Hee LeeChang Y Lee, 65Myong Chu Jin, 62
Connected to:
A Lee, 45Abi A Lee, 31Abigail LeeAbu B Lee, 66Adela C Lee, 64Adelyn S Lee, 39Adrian J Lee, 36Adriane C Lee, 57Aen H Lee, 44Aeren Lee, 33

Iris Lee Phones & Addresses

  • Buena Park, CA

Publications

Us Patents

Complement Factor Bb Antibodies

View page
US Patent:
20190071492, Mar 7, 2019
Filed:
Sep 26, 2018
Appl. No.:
16/142421
Inventors:
- Irvine CA, US
Chen Li - Irvine CA, US
Iris Lee - La Canada CA, US
Victor M. Guzman - Santa Ana CA, US
International Classification:
C07K 16/18
A61K 39/00
Abstract:
The present disclosure relates to antibodies and polynucleotides encoding the same, which may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement Factor Bb. Specifically, the disclosure is related to anti-complement Factor Bb antibodies.

Complement Factor Bb Antibodies

View page
US Patent:
20180057576, Mar 1, 2018
Filed:
Oct 23, 2017
Appl. No.:
15/790759
Inventors:
- Irvin CA, US
Chen Li - Irvine CA, US
Iris Lee - La Canada CA, US
Victor M. Guzman - Santa Ana CA, US
International Classification:
C07K 16/18
Abstract:
The present disclosure relates to antibodies and polynucleotides encoding the same, which may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement Factor Bb. Specifically, the disclosure is related to anti-complement Factor Bb antibodies.

Complement Factor Bb Antibodies

View page
US Patent:
20150239987, Aug 27, 2015
Filed:
Feb 25, 2015
Appl. No.:
14/631057
Inventors:
- Irvine CA, US
Chen Li - Irvine CA, US
Iris Lee - La Canada CA, US
Victor M. Guzman - Santa Ana CA, US
International Classification:
C07K 16/40
A61K 39/395
Abstract:
The present disclosure relates to antibodies and polynucleotides encoding the same, which may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement Factor Bb. Specifically, the disclosure is related to anti-complement Factor Bb antibodies.
Control profile
Iris Lee from Buena Park, CA Get Report